AstraZeneca AZN announced that the FDA has expanded the label of its cancer drug Datroway for a second indication — non-small cell lung cancer (NSCLC). The drug has been developed in partnership ...

AstraZeneca secured a fast approval of lung and breast cancer drugs with usually sluggish Japanese regulators, just months after scoring similar approvals in the West. The Japanese Ministry of ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

Companies such as AstraZeneca, Daiichi Sankyo, Pfizer, Merck and GSK are learning from previous setbacks in the ADC space to develop drugs that improve efficacy and reduce side effects.

Several factors are driving this expansion, including rising cancer ... AstraZeneca PLC (NASDAQ: AZN). Grand View Research continued: “The increasing prevalence of life-threatening conditions and the ...

According to the Lung Cancer Research Foundation, an estimated 226,650 people will be diagnosed with lung cancer in 2025 in the U.S. Around 124,730 Americans die from lung cancer each year.

It started a business to give hospitals better access to specialty drugs — for conditions like cancer, H.I.V. and autoimmune diseases — which are major drivers of 340B’s growth.

“Compare this with mammography, which about two-thirds of women get when they hit a certain age,” he said. Is lung cancer screening worth it? Under previous guidelines, 14.3 million people in ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years. A British ...

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...